EMAS Evaluation Study
Emas Evaluation Study
In December 2014 to December 2016, SID was conducting a evaluation study of Expanding Maternal and Neonatal Survival (EMAS) funded by USAID and JHPIEGO in collaboration with RTI International along with other Indonesian government agencies (national, provincial and local), Civil Society Organizations, public and private health facilities, hospital associations, professional organizations, and the private sector.
The Expanding Maternal and Neonatal Survival (EMAS) program aims to assist the Government of Indonesia in reducing maternal and neonatal mortality, and is expected to contribute to an overall 25% decline in national maternal and newborn mortality. The EMAS project is a five-year program (October 2011 September 2016). It is being implemented in 150 hospitals and 300 community health centers across 30 districts, in six provinces with the largest concentrations of maternal and newborn deaths. Provinces with the greatest number of deaths were selected, including a province from Sumatra, all provinces in Java and a province from Sulawesi which together account for almost 70% of all maternal deaths and 75% of newborn deaths primarily from preventable causes. The program aims to reduce maternal and neonatal mortality through delivery of three main components, including improving the quality of emergency obstetric and neonatal care services in hospitals and community health centers; and increasing the efficiency and effectiveness of referral systems between community health centers and hospitals.
EMAS project by specifically assessing: (1) the quality of clinical care and its association with improved emergency obstetric and newborn outcomes using the specific instruments already developed by the EMAS team; (2) the efficiency and effectiveness of the referral system to reduce time to care using the qualitative data collection instruments for referral developed by the EMAS team, and (3) the effectiveness of clinical and community governance in improving the coverage and provision of evidence-based, quality maternal and newborn interventions using the qualitative tools developed by the EMAS team, and, (4) the impact of the EMAS program on reducing maternal and neonatal mortality and obstetric and newborn complications using the service statistics data that have been collected during the implementation of EMAS.